| __timestamp | Summit Therapeutics Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 6795238 | 1244910 |
| Thursday, January 1, 2015 | 7454247 | 5029636 |
| Friday, January 1, 2016 | 10345862 | 4846776 |
| Sunday, January 1, 2017 | 16984203 | 5329003 |
| Monday, January 1, 2018 | 16187290 | 7121000 |
| Tuesday, January 1, 2019 | 9299233.54 | 9128000 |
| Wednesday, January 1, 2020 | 19232000 | 10731000 |
| Friday, January 1, 2021 | 23611000 | 10701000 |
| Saturday, January 1, 2022 | 26700000 | 16121000 |
| Sunday, January 1, 2023 | 28215000 | 37021000 |
Unlocking the unknown
In the competitive landscape of biotechnology, understanding the financial strategies of leading companies is crucial. Over the past decade, Summit Therapeutics Inc. and Viking Therapeutics, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Summit Therapeutics saw a steady increase in SG&A expenses, peaking at approximately $28 million in 2023, marking a 315% rise from 2014. In contrast, Viking Therapeutics experienced a more volatile trajectory, with a significant surge in 2023, reaching nearly $37 million, a staggering 2,870% increase from 2014. This divergence highlights differing strategic priorities, with Summit focusing on consistent growth and Viking on aggressive expansion. These insights provide a window into the operational priorities and market positioning of these biotech firms, offering valuable lessons for investors and industry analysts alike.
SG&A Efficiency Analysis: Comparing Pfizer Inc. and Summit Therapeutics Inc.
Selling, General, and Administrative Costs: Incyte Corporation vs Summit Therapeutics Inc.
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and Sarepta Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Summit Therapeutics Inc. and Lantheus Holdings, Inc.
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Ionis Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and Protagonist Therapeutics, Inc.
Summit Therapeutics Inc. or Supernus Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Summit Therapeutics Inc. vs Galapagos NV
Bio-Techne Corporation or Viking Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Viking Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Viking Therapeutics, Inc. or Catalyst Pharmaceuticals, Inc.
Viking Therapeutics, Inc. and Mesoblast Limited: SG&A Spending Patterns Compared